OLD Category: FFPE

Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers

• Lehto TK, Sturenberg C, Malen A, Erickson AM, Koistinen H, Mills IG, Rannikko A, Mirtti T

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

• Gandhi MK, Hoang T, Law SC...Bojarczuk K, Chapuy B, Keane C

Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19

• Bearse M, Hung YP, Krauson AJ...Chebib I, Newton-Cheh C, Stone JR

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer

• Quintana A, Peg V, Prat A...Vazquez M, De Mattos-Arruda L, Cortes J

A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer

• Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions

• Butler D, Mozsary C, Meydan C, Foox J, Rosiene J, Shaiber A, Danko D, Afshinnekoo E, MacKay M, Sedlazeck FJ, Ivanov NA, Sierra M, Pohle D, Zietz M, Gisladottir U, Ramlall V, Sholle ET, Schenck EJ, Westover CD, Hassan C, Ryon K, Young B, Bhattacharya C, Ng DL, Granados AC, Santos YA, Servellita V, Federman S, Ruggiero P, Fungtammasan A, Chin CS, Pearson NM, Langhorst BW, Tanner NA, Kim Y, Reeves JW, Hether TD, Warren SE, Bailey M, Gawrys J, Meleshko D, Xu D, Couto-Rodriguez M, Nagy-Szakal D, Barrows J, Wells H, O'Hara NB, Rosenfeld JA, Chen Y, Steel PAD, Shemesh AJ, Xiang J, Thierry-Mieg J, Thierry-Mieg D, Iftner A, Bezdan D, Sanchez E, Campion TR Jr, Sipley J, Cong L, Craney A, Velu P, Melnick AM, Shapira S, Hajirasouliha I, Borczuk A, Iftner T, Salvatore M, Loda M, Westblade LF, Cushing M, Wu S, Levy S, Chiu C, Schwartz RE, Tatonetti N, Rennert H, Imielinski M, Mason CE

Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant- IDH1 cholangiocarcinoma

• Aguado-Fraile E, Tassinari A, Ishii Y, Sigel C, Lowery MA, Goyal L, Gliser C, Jiang L, Pandya SS, Wu B, Bardeesy N, Choe S, Deshpande V

NTRK fusion in Japanese colorectal adenocarcinomas

• Yamashiro Y, Kurihara T, Hayashi T, Suehara Y, Yao T, Kato S, Saito T

Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile

• Younis RH, Ghita I, Elnaggar M...Webb TJ, Bentzen SM, Lubek JE

Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy

• Chen HZ, Bonneville R, Paruchuri A...Shields P, Carbone DP, Roychowdhury S

NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer

• Pappas K, Martin TC, Wolfe AL, Nguyen CB, Su T, Jin J, Hibshoosh H, Parsons R

Distinct Signatures of Genomic Copy Number Variants Define Subgroups of Merkel Cell Carcinoma Tumors

• Hill NT, Kim D, Busam KJ, Chu EY, Green C, Brownell I